Claim Missing Document
Check
Articles

Found 29 Documents
Search

Penyuluhan tentang Kenali dan Waspada Corona Virus Diseases of 2019 (Covid-19) pada Acara Hari Bebas Kendaraan Bermotor Kota Padang Russilawati Russilawati; Irvan Medison; Afriani Afriani; Yessy Susanty Sabri
Warta Pengabdian Andalas Vol 27 No 2 (2020)
Publisher : Lembaga Penelitian dan Pengabdian kepada Masyarakat (LPPM) Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jwa.27.2.119-125.2020

Abstract

Mysterious atypical pneumonia appeared abruptly in Wuhan, China in December 2019. China authority and Word Health Organization (WHO) found out the etiology on January 2020. New strain of Corona virus that eventually called by SARS-CoV2 has been responsible for the Corona virus disease of 2019 (Covid-19). The disease has ability to spread from human to human. These diseases had been pandemic since March 2020. As the start of early spreading we need to give right information about Covid-19 to the community so that the mass panicked could be avoided. We also need to educate community to take right precaution and prevention. These activities aims to spread the right information about Covid-19 and give simple training to performed prevention act so that community can slowdown the disease transmission. Methods: the campaign and health education about covid-19 and training of cough etiquette, right steps of hand washing using water and soap or alcohol based hand rub, and also how to use face mask properly. There were 66 participants that involved in this event. Participants had actively asked information about frequency of hand washing we need to prevent transmission and travel safety. We also performed flash mob so the participants could train cough etiquette, hand washing, and using face mask in fun ways. We ended the activities with competition of hand washing and using face mask properly. The door prize for the winner was hand sanitizer and face mask that they could use as tools to prevent transmission of Covid-19.
Peningkatan Komitmen Penanggulangan Covid-19 Mahasiswa melalui Webinar dan Deklarasi SIAGA SAKATO Liganda Endo Mahata; Fitrisia Amelin; Fathiyyatul Khaira; Denada Florencia Leona; Andani Eka Putra; Rizanda Machmud; Irvan Medison; Hardisman Hardisman; Yefri Zulfiqar; Fenty Anggraini; Linosefa Linosefa; Desy Nofita Sari; Rahmat Syawqi
Warta Pengabdian Andalas Vol 28 No 3 (2021)
Publisher : Lembaga Penelitian dan Pengabdian kepada Masyarakat (LPPM) Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jwa.28.3.225-231.2021

Abstract

The Covid-19 virus is transmitted from human to human through close contact with infected people through their respiratory droplets. A person can also be infected by touching an object contaminated with SARS-CoV-2 and then followed by reaching the eyes, nose, or mouth. Implementing the health protocol is necessary to reduce the number of virus transmissions. In addition, to increase the community's immune against Covid-19, WHO and the government have been developing a vaccination program. However, the recommendation from the latest research stated that people still have to obey the health protocol even after being vaccinated. The purpose of this community service was to help the government to increase people's understanding of the importance of implying health protocols, even after vaccination, to suppress Covid-19 cases. The method used is by holding an online event called a Webinar. It followed by a statement with audiences to commit to implementing the health protocol led by the Rector of Andalas University, then called a SIAGA SAKATO declaration. The activity began with a pre-test questionnaire for initial information collection, followed by education about Covid-19 prevention from the experts to the 512 students. The activity ended with the final data collection using a posttest questionnaire to test the student knowledge after the education. Paired t-test analysis showed a significant increase in student commitment after attending the Webinar (P≤0.05). Based on these results, the Webinar increases students' understanding of the importance of the health protocol in reducing the Covid-19 cases.
PENGGUNAAN IV KATETER PADA PENATALAKSAAN EMFISEMA SUBKUTIS Oea Khairsyaf; Irvan Medison
Majalah Kedokteran Andalas Vol 33, No 1: April 2009
Publisher : Faculty of Medicine, Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (336.759 KB) | DOI: 10.22338/mka.v33.i1.p%p.2009

Abstract

AbstrakDilaporkan seorang wanita usia 24 tahun di rujuk ke RSUP DR. M Djamil Padang dengan keluhan utama sesak nafas sejak tiga hari sebelumnya. Sesak nafas disertai oleh pembengkakan pada leher, wajah dan dinding dada. Pada riwayat penyakit sebelumnya didapatkan ia telah menderita asma sejak masa anak-anak.Diagnosis ditegakkan sebagai emfisema subkutis akibat eksaserbasi asma berat. Penatalaksanaan terapi berupa pemasangan kateter abocath no.14F yang telah di modifikasi subkutan.Pasien di rawat selama empat hari, kemudian dibolehkan pulang.Kata kunci: emfisema – asma – IV kateterAbstractTwenty four years old female patient admitted to the hospital with symptom of dyspnea since three days before entered the hospital. Dyspnea was accompanied by swelling in the neck, face and chest wall. She had suffered of asthma since a child.Patient was diagnosed as subcutaneous emphysema due to severe excacerbation of asthma. The treatment was treated with the insertion of modified abocath no. 14F subcutaneously.The patient was hospitalized for 4 days and went home with recovery.Keywords : emphysema – asthma – IV catheterLAPORAN KASUS
BRONKOSKOPI SEBAGAI PROSEDUR DIAGNOSTIK DAN TERAPEUTIK PENYAKIT PARU Sari, Elsa Purnama; Khairsyaf, Oea; Medison, Irvan
JAMBI MEDICAL JOURNAL "Jurnal Kedokteran dan Kesehatan" Vol. 9 No. 3 (2021): JAMBI MEDICAL JOURNAL Jurnal Kedokteran Dan Kesehatan
Publisher : FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (527.686 KB)

Abstract

Abstract Bronchoscopy is a medical procedure that provides tracheobronchial visualization by placing an optical instrument (bronchoscope) into the airways and is performed by a competent doctor. Bronchoscopy was invented by Gustav Killian in 1897 and since then the techniques have continued to develop. In 1966 Shigeto Ikeda introduced flexible bronchoscopy with fiber optic imaging technology. This is a revolution in the field of bronchoscopy. As cases of lung disease become more complex and the need for minimally invasive procedures, the contribution of bronchoscopy becomes increasingly important. This procedure has had significant developments in the last two decades. The latest bronchoscopy technology allows us to look outside the endobronchial tree to the mediastinum using endobronchial ultrasound (EBUS). Then the small nodules located in the periphery can also be traced for sampling using an electromagnetic navigation bronchoscopy (ENB). We can also manipulate the airway muscles to reduce asthma symptoms using bronchial thermoplasty. This paper is written to describe the basic principles of bronchoscopy and its clinical application in the diagnostic and therapeutic measures of pulmonary disease. Keywords: Bronchoscopy, Diagnostic, Therapeutic
Pleural Amebiasis without Hepar Involvement Handayani, Friska; Medison, Irvan; Fitrina, Dewi Wahyu; Mizarti, Dessy
MAGNA MEDICA Berkala Ilmiah Kedokteran dan Kesehatan Vol 10, No 2 (2023): August
Publisher : Universitas Muhammadiyah Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26714/magnamed.10.2.2023.229-238

Abstract

Background:  Pleuropulmonary amebiasis is the most common complication of amoebic liver abscess, occurring in 15% of patients with amoebic liver disease and in 1% of patients with amoebic dysentery. Most commonly occurs by direct extension of a right superior lobe hepatic abscess through the diaphragm to the right lower lobe of the lung with a mortality rate of 5-16%. Primary pleural amebiasis without liver involvement is rare.Case Presentation: Reported an 18-year-old male patient with pleural amebiasis from the results of parasitological examination of pleural fluid found Entamoeba histolytica. History, physical examination and support showed normal liver function. The patient has a history of poor sanitation with a dissertation of unhygienic habits. Patients without liver problems remain at risk for amoebiasis pleuraConclusion: Pleural amebiasis without liver involvement was a rare case. Further investigation was needed in patients with pleural amoebiasis to other organs, such as the liver and digestive tract. Diagnose pleural amebiasis should be the main focus in determining the etiology. Entamoeba histolytica may be involved in pleural inflammation and cause effusion.
Co-Existence of Tuberculosis and Lung Cancer Aribowo, Kornelis; Medison, Irvan; Mizarti, Dessy; Fitrina, Dewi Wahyu
MAGNA MEDICA Berkala Ilmiah Kedokteran dan Kesehatan Vol 9, No 1 (2022): February
Publisher : Universitas Muhammadiyah Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26714/magnamed.9.1.2022.51-61

Abstract

Background: Tuberculosis (TB) and lung cancer cause significant morbidity and mortality worldwide and pose a global health threat. Each year these two diseases account for more than 1.6 million deaths worldwide. The incidence of both diseases is still high in many developing countries, especially in Asian countries. TB and lung cancer are often confused and misdiagnosed, especially in countries with diagnostic challenges of low TB incidence and risk of missed diagnosis.Case Presentation: The following is a case report of a 53-year-old male patient diagnosed with pulmonary TB accompanied by right lung cancer, and the same respiratory complaints can be had by lung cancer and TB. However, the presence of facial edema (part of the superior vena cava syndrome) causes clinicians to focus more on lung cancer so that the diagnosis of TB is often overlooked.Conclusion: Tuberculosis should be a significant concern, especially in patients with malignancies such as lung cancer and located in TB endemic areas. Delay in diagnosis and or miss diagnosis will affect the patient's outcome.
Diagnosis And Management Of Pulmonary Tuberculosis In Hiv With Severe Immunodeficiency Rizki, Fitri Amelia; Medison, Irvan; Anggrainy, Fenty
PROFESSIONAL HEALTH JOURNAL Vol. 7 No. 1 (2025): In Progress issue
Publisher : Pusat Penelitian dan Pengabdian Masyarakat (PPPM) STIKES Banyuwangi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54832/phj.v7i1.1016

Abstract

The total number of TB cases in Indonesia is 969,000. This figure represents a 17% increase compared to 2020. SITB 2022 data shows there are 15,375 cases of co-infection of pulmonary TB with HIV. The treatment success rate for pulmonary TB co-infection with HIV in Indonesia in 2022 is 71%. This is still far from the national target of 90%.This case report discusses a 33-year-old man with pulmonary TB and TB lymphadenitis with HIV at clinical stage 4. The CD4 count was 10 cells/mm3. The degree of immunodeficiency suffered by this patient is severe immunodeficiency. The management was to administer OAT first, followed by ART within 2 weeks after OAT was administered and well tolerated. OAT was administered for 9 months due to the presence of TB lymphadenitis. Treatment evaluation showed clinical improvement and the patient did not develop IRIS. The incidence of IRIS in patients with TB is 8%-43%. Factors influencing the occurrence of IRIS include the CD4 count at the start of ART.
Diagnosis And Management Of Pulmonary Tuberculosis In Hiv With Severe Immunodeficiency Rizki, Fitri Amelia; Medison, Irvan; Anggrainy, Fenty
PROFESSIONAL HEALTH JOURNAL Vol. 7 No. 1 (2025): December
Publisher : Pusat Penelitian dan Pengabdian Masyarakat (PPPM) STIKES Banyuwangi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54832/phj.v7i1.1016

Abstract

The total number of TB cases in Indonesia is 969,000. This figure represents a 17% increase compared to 2020. SITB 2022 data shows there are 15,375 cases of co-infection of pulmonary TB with HIV. The treatment success rate for pulmonary TB co-infection with HIV in Indonesia in 2022 is 71%. This is still far from the national target of 90%.This case report discusses a 33-year-old man with pulmonary TB and TB lymphadenitis with HIV at clinical stage 4. The CD4 count was 10 cells/mm3. The degree of immunodeficiency suffered by this patient is severe immunodeficiency. The management was to administer OAT first, followed by ART within 2 weeks after OAT was administered and well tolerated. OAT was administered for 9 months due to the presence of TB lymphadenitis. Treatment evaluation showed clinical improvement and the patient did not develop IRIS. The incidence of IRIS in patients with TB is 8%-43%. Factors influencing the occurrence of IRIS include the CD4 count at the start of ART.
Management Strategies and Outcomes for Bilateral Pulmonary Hydatid Cysts: A Systematic Review and Meta-Analysis Berliana Islamiyarti Hydra; Irvan Medison; Fenty Anggrainy
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 9 No. 7 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v9i7.1342

Abstract

Background: Bilateral pulmonary hydatid disease presents a complex therapeutic challenge, necessitating careful consideration of surgical timing, approach, and adjuvant medical therapy to optimize patient outcomes while minimizing morbidity. This systematic review and meta-analysis aimed to evaluate the different management strategies and their associated outcomes in patients with bilateral pulmonary hydatid cysts. Methods: A systematic search of PubMed, Embase, Scopus, and Web of Science databases was conducted for studies published between January 2014 and December 2024, reporting on management strategies (one-stage bilateral surgery, two-stage bilateral surgery, medical therapy) and outcomes (postoperative complications, recurrence, mortality, length of hospital stay) in patients with bilateral pulmonary hydatid cysts. Studies were selected based on predefined inclusion and exclusion criteria. Data were extracted by two independent reviewers, and quality assessment was performed using a modified Newcastle-Ottawa Scale. Pooled proportions for outcomes were calculated using random-effects models. Heterogeneity was assessed using the I2 statistic. Results: Seven studies, encompassing a total of 305 patients with bilateral pulmonary hydatid cysts, met the inclusion criteria. The studies varied in design, including retrospective cohorts and prospective case series. Management predominantly involved surgical intervention, with 148 patients (48.5%) undergoing one-stage bilateral surgery and 127 patients (41.6%) undergoing two-stage procedures. Perioperative albendazole was administered to 245 patients (80.3%). The pooled overall postoperative complication rate was 28.7% (95% CI: 21.5%-36.8%; I2=78%). Major complications occurred in 12.1% (95% CI: 8.0%-17.9%; I2=65%). The pooled recurrence rate at a mean follow-up of 38.5 months was 8.5% (95% CI: 5.1%-13.8%; I2=55%). Overall mortality was 2.1% (95% CI: 0.9%-4.5%; I2=0%). Patients undergoing one-stage surgery exhibited a trend towards higher overall complication rates (33.1% vs. 25.2% for two-stage) but shorter total hospital stays. Adjuvant albendazole therapy was associated with a trend towards lower recurrence rates. Conclusion: Surgical management, whether one-stage or two-stage, remains the cornerstone of treatment for bilateral pulmonary hydatid disease, achieving acceptable morbidity and mortality with good long-term control in most patients. Postoperative complications are relatively common, highlighting the complexity of these cases. While one-stage surgery may shorten overall hospital stay, it might be associated with a higher risk of immediate complications. Adjuvant albendazole appears beneficial in reducing recurrence. The choice of surgical strategy should be individualized based on patient status, cyst characteristics, and surgical expertise. Further prospective, comparative studies are needed to delineate optimal management pathways.
Navigating a Therapeutic Triad: A Case of Pulmonary Tuberculosis Complicated by Drug-Induced Liver Injury and Prediabetes Yuni Kartika; Irvan Medison; Dessy Mizarti
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 9 No. 9 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v9i9.1372

Abstract

Background: The management of pulmonary tuberculosis (TB) is frequently complicated by adverse drug reactions, with drug-induced liver injury (DILI) being one of the most severe. The clinical challenge is significantly amplified in patients with underlying metabolic disorders such as prediabetes, which can impair immune responses and affect treatment outcomes. This report details the complex management of a geriatric patient presenting with this therapeutic triad. Case presentation: A 67-year-old male with newly diagnosed, drug-sensitive pulmonary tuberculosis developed severe hepatotoxicity ten days after initiating standard first-line anti-tuberculosis therapy. Clinical presentation included jaundice, nausea, and vomiting, with laboratory findings showing a severe hepatocellular injury pattern (SGOT 204 U/L, SGPT 126 U/L) and hyperbilirubinemia (Total Bilirubin 2.6 mg/dL). Concurrently, he was diagnosed with prediabetes (HbA1c 5.9%) and was suffering from severe malnutrition (BMI 15.6 kg/m²). The offending drugs were immediately withdrawn, and supportive therapy was initiated. Following normalization of liver function, a modified anti-tuberculosis regimen was cautiously reintroduced using a stepwise re-challenge protocol that entirely omitted pyrazinamide. Conclusion: The patient was successfully managed with a modified nine-month regimen of isoniazid, rifampicin, and ethambutol, achieving clinical and biochemical stability without recurrence of liver injury. This case highlights that a meticulous, stepwise approach—involving prompt drug withdrawal, supportive care, and a tailored re-challenge protocol—can lead to successful TB treatment outcomes without recurrence of DILI, even in a patient with multiple converging high-risk factors.